photo
Speaker

Jin-San Yoo

CEO, PHARMABCINE
Daejeon,, Korea - South Korea
Dr. Jin-San Yoo is CEO, President and Founder of PharmAbcine (http://www.pharmabcine.com/), clinical
stage public biotech developing innovative oncology drugs. He is acting an expert at MAB working group of
EDQM (https://www.edqm.eu/). He also is acting as member of evaluation committee of MFDS
(https://www.mfds.go.kr/eng/index.do). He has >18 years of biopharm/biotech experience. As the head of
TAD(Therapeutic Antibody Division), he established all necessary infrastructures, talented pool and
competitive pipelines at LG Chem R&D Park (http://www.lgchem.com/global/main). As a principal
investigator and director of TTAC (The Therapeutic Antibody Center) at KRIBB
(https://www.kribb.re.kr/eng/), he leaded his research team to focus on development of novel therapeutic
antibodies.  Dr. Yoo has authored numerous papers in peer reviewed journals, book chapters and he is also
an inventor of several patents and patent applications.
Speaking In
[Available On-Demand]
PharmAbcine is a clinical stage public company in KOSDAQ market(208340) and focusing on next…